Comparison of Remimazolam-Flumazenil versus Propofol for Rigid Bronchoscopy: A Prospective Randomized Controlled Trial

Background: Remimazolam is a novel ultrashort-acting intravenous benzodiazepine sedative–hypnotic that significantly reduces the times to sedation onset and recovery. This trial was conducted to confirm the recovery time from anesthesia of remimazolam-flumazenil versus propofol in patients undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yafei, Chen, Mo, Gu, Fulei, Chen, Jinyan, Zhang, Wen, Huang, Zhangxiang, Zhu, Dapeng, Song, Jia, Fang, Jun, Yu, Weifeng, Xie, Kangjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821250/
https://www.ncbi.nlm.nih.gov/pubmed/36615057
http://dx.doi.org/10.3390/jcm12010257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821250/
https://www.ncbi.nlm.nih.gov/pubmed/36615057
http://dx.doi.org/10.3390/jcm12010257

Ejemplares similares